Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-03

Clinical Trial Update: Evaluation of Superiority of Valsartan+Celecoxib+Metformin Over Metformin Alone in Type 2 Diabetes Patients [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating whether adding valsartan and celecoxib to metformin provides superior outcomes versus metformin alone in Type 2 Diabete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Celecoxib (Celecoxib)
  • VALSARTAN (Valsartan)
  • metformin (metformin)

Snippet

Sponsor: ARKAY Therapeutics | Conditions: Type 2 Diabetes, High Blood Pressure | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING